Stage IVB Prostate Cancer AJCC v8 Recruiting Phase 2 Trials for Goserelin (DB00014)

DBCOND0109404 (Stage IVB Prostate Cancer AJCC v8)Recruiting2 IdentifierTitlePurposeDrugs
NCT06378866Stereotactic Body Radiation Therapy Plus Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy for Treatment of Metastatic, Recurrent Hormone-Sensitive Prostate Cancer, DIVINE TrialTreatment
NCT04734730Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate CancerTreatment